Current economic evaluation and analytical techniques are applied to decision problems faced by the space bioprocessing program. NASA decision makers are enabled to choose candidate substances, after ranking them according to their potential economic benefit. The determination of appropriate evaluation techniques necessary to obtain measures of potential economic benefits which result from the pursuit of various space bioprocessing endeavors are focused upon. The treatment of each disease is impacted by a successful outcome of space bioprocessing and specify data and other input needs for each candidate substance.
